GGrantIndex
← Leaderboards

Honami Naora

University Of Texas Md Anderson Can Ctr

$11,108,433
Attributed
$11,108,433
Total exposure
11
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,108,433 · 11

By mechanism

R01$9,061,650 · 5
R21$1,884,783 · 5
R03$162,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorInsightMalignant Neoplasm Of OvaryCellsGrowthCancer CellDiagnosisStemCancer PatientXenograft ModelResponseClinical ManagementSiteChemotherapySpecimenBaseWomanStromal CellsMalignant NeoplasmsMediatingPlayTumor GrowthHomeobox GenesTissues

Grant awards (33)

Impact of aging on metastatic competence of the omentum$2,638,738
R01 · FY2025 · CA · contact PI
Boosting anti-tumor immunity in the omentum for metastasis prevention$215,846
R21 · FY2024 · CA · contact PI
Isolation of miRNA-rich extracellular vesicles for liquid biopsy$222,661
R21 · FY2023 · CA · contact PI
Boosting anti-tumor immunity in the omentum for metastasis prevention$189,338
R21 · FY2023 · CA · contact PI
Pre-metastatic Omental Niche Formation in Ovarian Cancer$353,518
R01 · FY2022 · CA · contact PI
Isolation of miRNA-rich extracellular vesicles for liquid biopsy$189,338
R21 · FY2022 · CA · contact PI
Impact of diagnostic peritoneal lavage on omentum metastasis$81,000
R03 · FY2022 · CA · contact PI
Pre-metastatic Omental Niche Formation in Ovarian Cancer$374,133
R01 · FY2021 · CA · contact PI
Impact of diagnostic peritoneal lavage on omentum metastasis$81,000
R03 · FY2021 · CA · contact PI
Pre-metastatic Omental Niche Formation in Ovarian Cancer$371,382
R01 · FY2020 · CA · contact PI
Mechanism of evasion by ovarian cancers from anti-VEGF therapy$366,000
R01 · FY2020 · CA · contact PI
Mechanism of evasion by ovarian cancers from anti-VEGF therapy$355,019
R01 · FY2019 · CA · contact PI
Pre-metastatic Omental Niche Formation in Ovarian Cancer$343,726
R01 · FY2019 · CA · contact PI
Pre-metastatic Omental Niche Formation in Ovarian Cancer$383,129
R01 · FY2018 · CA · contact PI
Mechanism of evasion by ovarian cancers from anti-VEGF therapy$366,000
R01 · FY2018 · CA · contact PI
Mechanism of evasion by ovarian cancers from anti-VEGF therapy$366,000
R01 · FY2017 · CA · contact PI
Transcriptional Control of Leukemic Evolution in Primary Myelofibrosis$174,000
R21 · FY2017 · CA · contact PI
Mechanism of evasion by ovarian cancers from anti-VEGF therapy$366,000
R01 · FY2016 · CA · contact PI
Transcriptional Control of Leukemic Evolution in Primary Myelofibrosis$208,800
R21 · FY2016 · CA · contact PI
Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes$174,000
R21 · FY2016 · CA · contact PI
Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes$208,800
R21 · FY2015 · CA · contact PI
Multifunctional roles of homeobox gene DLX4 in ovarian cancer$308,475
R01 · FY2014 · CA · contact PI
Multifunctional roles of homeobox gene DLX4 in ovarian cancer$298,934
R01 · FY2013 · CA · contact PI
Multifunctional roles of homeobox gene DLX4 in ovarian cancer$318,015
R01 · FY2012 · CA · contact PI
Multifunctional roles of homeobox gene DLX4 in ovarian cancer$318,015
R01 · FY2011 · CA · contact PI
Multifunctional roles of homeobox gene DLX4 in ovarian cancer$327,850
R01 · FY2010 · CA · contact PI
HOX genes in ovarian neoplasia$234,808
R01 · FY2008 · CA · contact PI
HOX genes in ovarian neoplasia$234,808
R01 · FY2007 · CA · contact PI
HOX genes in ovarian neoplasia$241,820
R01 · FY2006 · CA · contact PI
HOX genes in ovarian neoplasia$247,640
R01 · FY2005 · CA
HOX genes in ovarian neoplasia$247,640
R01 · FY2004 · CA
Antibodies to homeobox proteins to detect ovarian cancer$151,000
R21 · FY2004 · CA
Antibodies to homeobox proteins to detect ovarian cancer$151,000
R21 · FY2003 · CA